Article Tag: Biotalys

Syngenta Crop Protection and Biotalys are collaborating to research, develop and commercialize new biocontrol solutions to manage key pests in a broad variety of crops. […]

Biotalys has established a Scientific Advisory Committee (SAC) that will support the company’s continued growth, accelerate product pipeline efforts and deepen scientific partnership initiatives. Timed […]

Biotalys and Novozymes announced the successful outcome of the feasibility study for Evoca, Biotalys’ first proprietary biocontrol product candidate. Through the study, Novozymes obtained proof […]

Biotalys and Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol. The partnership provides that Novozymes will use its […]

Biotalys announced that the Fungicide Resistance Action Committee (FRAC) granted a new class for the active ingredient of its first biofungicide, Evoca. Evoca is a […]

Biotalys has appointed Dr. Carlo Boutton as chief scientific officer (CSO), effective 3 May 2022. In his most recent role as Sanofi’s global head of […]

Biotalys and Kwizda Agro announced an agreement for Kwizda Agro to act as the formulator of the protein-based biocontrol products developed by Biotalys. Biotalys’ products […]

Biotalys and Biobest have entered into a long-term partnership whereby Biotalys will offer Biobest a right of first negotiation to reach an exclusive distribution agreement […]

Biotalys and Olon, a contract development and manufacturing organization, have entered into a long-term strategic partnership for the manufacturing of Biotalys’ biocontrol products. Under the […]

Biotalys has been awarded a multi-year grant from the Bill & Melinda Gates Foundation to discover novel antifungal biocontrols for deployment to smallholder farmers. The […]

Belgian biotech company Biotalys flexed its muscle earlier this year with a public listing raising €52.8 million. Focused on protein-based biocontrol utilizing nanobodies, the company […]

Biotalys announced the appointment of Patrick McDonnell as chief business officer, effective 4 October 2021. McDonnell will be based in Biotalys’ offices in Research Triangle […]

Biotalys expects to secure US Regulatory approval for its  first protein-based biofungicide product, Evoca, and sees a 2024 launch in the European Union. The company […]

Biotalys plans to list on Euronext Brussels, hoping to attract investors with its biological alternatives to chemical pesticides. Biotalys has seven potential products it intends […]

Biotalys has appointed Simon Moroney as chairman of the board. Moroney brings over 30 years of industry leadership and research experience to the Biotalys board. […]

Biotalys has submitted the registration dossier for the active substance of its first protein-based biocontrol product, Evoca, for EU approval. Evoca is Biotalys’ first biofungicide […]

Biotalys NV submitted its first protein-based biocontrol, Evoca, to the Environmental Protection Agency (EPA) in the United States for approval. Pending EPA registration, this biocontrol […]

Biotalys NV has been awarded a €1.1 million research grant from Flanders Innovation & Entrepreneurship (VLAIO). The grant will run over three years and will […]

Biotalys NV has appointed Wim Ottevaere as chief financial officer. Ottevaere will provide strategic financial leadership and will be focused on supporting the organization towards […]

Biotalys NV has established a new U.S. subsidiary, Biotalys, Inc., located in Research Triangle Park, North Carolina. Biotalys is preparing for the commercial launch of […]

Biotalys NV has been awarded a €1.6 million research grant from Flanders Innovation Entrepreneurship (VLAIO). The grant will run over three years and will support […]

Diego Angelo has been appointed to the newly created role of chief business officer and head of Biotalys Inc., a new subsidiary of Biotalys NV. […]

Biotalys NV announced the formation of a scientific advisory board (SAB) comprised of industry experts and thought leaders to provide scientific and technical advice aiming […]

Biotalys NV announced the results from more than 100 field trials with its first biofungicide, BioFun-1, which is on track to launch in the US […]

Biotalys NV announced the second closing of its Series C financing round with €10 million, bringing the total amount of capital raised through its Series […]

Biotalys NV is collaborating with Chrysal to protect flowers against fungal diseases using its new generation biofungicide. The study will be conducted at Chrysal in […]

AgroSavfe NV, a food and crop protection company that develops protein-based biocontrols, announced in December that its company name has changed to Biotalys. In addition, […]